ANI Pharmaceuticals Inc (ANIP) Insider Trading
- $2,005,711.60
- $142,151,134.77
- Sept. 12, 2025
- Muthusamy Shanmugam
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 13, 2024 | VP | 250 | $67.69 | Sell | $16,922.50 | |
May 1, 2024 | SVP | 20,000 | $66.62 | Sell | $1,332,400.00 | |
April 19, 2024 | COO | 16,809 | $65.17 | Sell | $1,095,442.53 | |
April 17, 2024 | COO | 9,520 | $65.40 | Sell | $622,608.00 | |
April 15, 2024 | COO | 7,414 | $66.33 | Sell | $491,770.62 | |
April 12, 2024 | VP | 250 | $67.79 | Sell | $16,947.50 | |
April 1, 2024 | SVP | 20,000 | $67.25 | Sell | $1,345,000.00 | |
March 11, 2024 | CFO | 7,787 | $65.55 | Sell | $510,437.85 | |
March 8, 2024 | CEO | 16,292 | $67.13 | Sell | $1,093,681.96 | |
March 7, 2024 | SVP | 24,338 | $66.37 | Sell | $1,615,313.06 | |
March 7, 2024 | COO | 15,085 | $66.35 | Sell | $1,000,889.75 | |
March 6, 2024 | CEO | 28,965 | $65.52 | Sell | $1,897,786.80 | |
March 5, 2024 | COO | 10,093 | $65.35 | Sell | $659,577.55 | |
Feb. 13, 2024 | VP | 250 | $56.04 | Sell | $14,010.00 | |
Jan. 22, 2024 | COO | 5,692 | $55.95 | Sell | $318,467.40 | |
Jan. 18, 2024 | COO | 9,784 | $55.30 | Sell | $541,055.20 | |
Jan. 16, 2024 | COO | 5,000 | $55.63 | Sell | $278,150.00 | |
Jan. 12, 2024 | VP | 250 | $56.43 | Sell | $14,107.50 | |
Dec. 18, 2023 | COO | 13,026 | $52.44 | Sell | $683,083.44 | |
Dec. 15, 2023 | COO | 11,974 | $52.44 | Sell | $627,916.56 | |
Dec. 11, 2023 | VP | 250 | $49.21 | Sell | $12,302.50 | |
Nov. 16, 2023 | COO | 6,448 | $51.66 | Sell | $333,103.68 | |
Nov. 15, 2023 | SVP | 2,622 | $53.81 | Sell | $141,089.82 | |
Nov. 14, 2023 | COO | 22,095 | $53.17 | Sell | $1,174,791.15 | |
Oct. 18, 2023 | COO | 6,242 | $57.78 | Sell | $360,662.76 | |
Oct. 16, 2023 | COO | 13,063 | $58.31 | Sell | $761,703.53 | |
Oct. 13, 2023 | COO | 11,937 | $57.58 | Sell | $687,332.46 | |
Oct. 2, 2023 | SVP | 20,000 | $56.48 | Sell | $1,129,600.00 | |
Sept. 18, 2023 | COO | 8,425 | $61.64 | Sell | $519,317.00 | |
Sept. 15, 2023 | COO | 16,242 | $62.81 | Sell | $1,020,160.02 | |
Sept. 1, 2023 | SVP | 20,000 | $64.70 | Sell | $1,294,000.00 | |
Aug. 28, 2023 | COO | 25,000 | $63.06 | Sell | $1,576,500.00 | |
Aug. 23, 2023 | SVP | 15,561 | $62.39 | Sell | $970,850.79 | |
Aug. 16, 2023 | Major Shareholder | 200,000 | $58.50 | Sell | $11,700,000.00 | |
Aug. 15, 2023 | CEO | 11,616 | $61.13 | Sell | $710,086.08 | |
Aug. 14, 2023 | Director | 3,000 | $60.37 | Sell | $181,110.00 | |
Aug. 14, 2023 | COO | 27,890 | $61.15 | Sell | $1,705,473.50 | |
Aug. 11, 2023 | CEO | 56,666 | $57.75 | Sell | $3,272,461.50 | |
Aug. 1, 2023 | SVP | 20,000 | $51.06 | Sell | $1,021,200.00 | |
July 21, 2023 | COO | 11,500 | $52.56 | Sell | $604,440.00 | |
July 19, 2023 | COO | 5,969 | $51.48 | Sell | $307,284.12 | |
July 17, 2023 | COO | 9,831 | $51.06 | Sell | $501,970.86 | |
July 14, 2023 | COO | 10,000 | $50.43 | Sell | $504,300.00 | |
July 3, 2023 | SVP | 20,000 | $53.43 | Sell | $1,068,600.00 | |
June 22, 2023 | SVP | 20,000 | $51.32 | Sell | $1,026,400.00 | |
June 22, 2023 | COO | 13,500 | $51.38 | Sell | $693,630.00 | |
June 20, 2023 | COO | 14,657 | $51.93 | Sell | $761,138.01 | |
Aug. 15, 2022 | SVP | 5,172 | $37.79 | Sell | $195,449.88 | |
Aug. 12, 2022 | SVP | 12,894 | $37.04 | Sell | $477,593.76 | |
March 21, 2022 | CEO | 7,224 | $27.69 | Buy | $200,032.56 |
Insiders are both buying and selling ANI Pharmaceuticals Inc stock.
The insider traders at ANI Pharmaceuticals Inc are: Muthusamy Shanmugam, Meredith Cook, Chad Gassert, Tracy Marshbanks, James G Marken, Meridian Venture Partners Ii L, Nikhil Lalwani, Arthur Przybyl, Krista Davis, Patrick D Walsh, Thomas Haughey, Robert W Schrepfer, Stephen P Carey, Ori Gutwerg, Ross J Mangano, Antonio R Pera, Jeanne Thoma, Matthew J Leonard, Christopher Mutz, Daniel Raynor, Renee P Tannenbaum, Thomas Andrew Rowland, David Nash, and Ross Mangano
The most active insider trader at ANI Pharmaceuticals Inc is Muthusamy Shanmugam with 36 trades.
Muthusamy Shanmugam has sold the most ANI Pharmaceuticals Inc stock with a total value of $45,394,142.03.
Patrick D Walsh has bought the most ANI Pharmaceuticals Inc stock with a total value of $846,760.00.
The most recent insider trade for ANI Pharmaceuticals Inc was on Sept. 12, 2025.
The single biggest insider buy for ANI Pharmaceuticals Inc was from Patrick D Walsh with a total value of $307,800.00 on Aug. 10, 2020.
The single biggest insider sell for ANI Pharmaceuticals Inc was from Meridian Venture Partners Ii L with a total value of $11,700,000.00 on Aug. 16, 2023.